Combined High-Throughput Proteomics and Random Forest Machine-Learning Approach Differentiates and Classifies Metabolic, Immune, Signaling and ECM Intra-Tumor Heterogeneity of Colorectal Cancer.

Journal: Cells
PMID:

Abstract

Colorectal cancer (CRC) is a frequent, worldwide tumor described for its huge complexity, including inter-/intra-heterogeneity and tumor microenvironment (TME) variability. Intra-tumor heterogeneity and its connections with metabolic reprogramming and epithelial-mesenchymal transition (EMT) were investigated with explorative shotgun proteomics complemented by a Random Forest (RF) machine-learning approach. Deep and superficial tumor regions and distant-site non-tumor samples from the same patients (n = 16) were analyzed. Among the 2009 proteins analyzed, 91 proteins, including 23 novel potential CRC hallmarks, showed significant quantitative changes. In addition, a 98.4% accurate classification of the three analyzed tissues was obtained by RF using a set of 21 proteins. Subunit E1 of 2-oxoglutarate dehydrogenase (OGDH-E1) was the best classifying factor for the superficial tumor region, while sorting nexin-18 and coatomer-beta protein (beta-COP), implicated in protein trafficking, classified the deep region. Down- and up-regulations of metabolic checkpoints involved different proteins in superficial and deep tumors. Analogously to immune checkpoints affecting the TME, cytoskeleton and extracellular matrix (ECM) dynamics were crucial for EMT. Galectin-3, basigin, S100A9, and fibronectin involved in TME-CRC-ECM crosstalk were found to be differently variated in both tumor regions. Different metabolic strategies appeared to be adopted by the two CRC regions to uncouple the Krebs cycle and cytosolic glucose metabolism, promote lipogenesis, promote amino acid synthesis, down-regulate bioenergetics in mitochondria, and up-regulate oxidative stress. Finally, correlations with the Dukes stage and budding supported the finding of novel potential CRC hallmarks and therapeutic targets.

Authors

  • Cristina Contini
    Department of Medical Sciences and Public Health, Statal University of Cagliari, 09042 Monserrato (CA), Italy.
  • Barbara Manconi
    Department of Life and Environmental Sciences, Statal University of Cagliari, 09042 Monserrato (CA), Italy.
  • Alessandra Olianas
    Department of Life and Environmental Sciences, Statal University of Cagliari, 09042 Monserrato (CA), Italy.
  • Giulia Guadalupi
    Department of Surgical Sciences, Statal University of Cagliari, 09042 Monserrato (CA), Italy.
  • Alessandra Schirru
    Department of Life and Environmental Sciences, Statal University of Cagliari, 09042 Monserrato (CA), Italy.
  • Luigi Zorcolo
    Department of Surgical Sciences, Statal University of Cagliari, 09042 Monserrato (CA), Italy.
  • Massimo Castagnola
    Laboratorio di Proteomica, Centro Europeo di Ricerca sul Cervello, IRCCS Fondazione Santa Lucia, 00179 Rome, Italy.
  • Irene Messana
    Istituto di Scienze e Tecnologie Chimiche "Giulio Natta", Consiglio Nazionale delle Ricerche, 00168 Roma, Italy.
  • Gavino Faa
    Department of Pathology, 09100, AOU of Cagliari, Italy.
  • Giacomo Diaz
    Department of Biomedical Sciences, Statal University of Cagliari, 09042 Monserrato (CA), Italy.
  • Tiziana Cabras
    Department of Life and Environmental Sciences, Statal University of Cagliari, 09042 Monserrato (CA), Italy.